descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2002 English Publisher:Mary Ann Liebert IncJournal:AIDS Patient Care and STDs, volume 16, pages 5-7 (issn: 1087-2914, eissn: 1557-7449,

Authors: Lori E. Fantry; Hinrich Staecker;

doi: 10.1089/108729102753429343

pmid: 11839213

Vertigo and Abacavir

- Summary
- Subjects
- Metrics

Abstract

Vertigo can cause significant morbidity and make a person unable to perform activities of daily life. A human immunodeficiency virus (HIV)-infected patient experienced vertigo while taking abacavir that resolved immediately on cessation of therapy. The mechanism by which abacavir appeared to be associated with vertigo in this patient is unknown.

Related Organizations

University of Maryland, College Park
United States
University of Maryland, Baltimore
United States

Keywords

Adult, Male, Anti-HIV Agents, HIV-1, Vertigo, Humans, HIV Infections, Dideoxynucleosides

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	9
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average